Recent Exposure to Four-Factor Prothrombin Complex Concentrate (4F-PCC) is Associated with Intracardiac Thrombus during Liver Transplantation.

被引：0
|
作者：
Misel, M. [1 ,2 ]
Schnickel, G. [1 ]
Berumen, J. [1 ]
Sanchez, R. [3 ]
Mekeel, K. [1 ]
机构：
[1] UC San Diego Hlth, Div Transplant & Hepatobiliary Surg, La Jolla, CA USA
[2] UC San Diego Hlth, Pharm Inpatient Serv, La Jolla, CA USA
[3] UC San Diego Hlth, Anesthesiol, La Jolla, CA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
A241
引用
收藏
页码：558 / 558
页数：1
相关论文
共 50 条
  • [41] Correction of INR and Coagulation Factor Levels in a Randomized Clinical Trial of Four-Factor Prothrombin Complex Concentrate (PCC-4) Versus Plasma for Urgent Vitamin K Antagonist Reversal
    Refaai, M. A.
    Goldstein, J. N.
    Milling, T. J.
    Foehl, H.
    Hug, B.
    Sarode, R.
    ANNALS OF EMERGENCY MEDICINE, 2012, 60 (04) : S10 - S10
  • [42] Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case series
    Liu, JiTong
    Elsamadisi, Pansy
    Philips, Eli
    Bauer, Kenneth A.
    Eche, Ifeoma M.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (16) : 1323 - 1329
  • [43] Four-Factor Prothrombin Complex Concentrate as a Strategy to Rapidly Reverse Anticoagulation in Patients Undergoing Cardiac Transplantation: Better Than the Conventional Approach?
    Sam, T.
    Gonzalez-Stawinski, G.
    Saracino, G.
    Jamil, A.
    Hall, S.
    Cox, K.
    Lima, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 554 - 555
  • [44] Does 4-factor prothrombin concentrate (4F-PCC) reduce 24 h blood product consumption in trauma patients at risk of massive transfusion?
    Newton, Hailey
    Drew, Doran
    Perry, Jeffrey J.
    CANADIAN JOURNAL OF EMERGENCY MEDICINE, 2023, 25 (12) : 946 - 948
  • [45] Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhages
    Pham, Haithuy
    Medford, Whitney Gibson
    Horst, Spencer
    Levesque, Melissa
    Ragoonanan, David
    Price, Christine
    Colbassani, Harold
    Piper, Keaton
    Chastain, Keith
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 55 : 38 - 44
  • [46] Does 4-factor prothrombin concentrate (4F-PCC) reduce 24 h blood product consumption in trauma patients at risk of massive transfusion?
    Hailey Newton
    Doran Drew
    Jeffrey J. Perry
    Canadian Journal of Emergency Medicine, 2023, 25 : 946 - 948
  • [47] SAFETY OF A 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE (4F-PCC) VERSUS PLASMA FOR VITAMIN K ANTAGONIST REVERSAL: AN INTEGRATED DATA ANALYSIS OF TWO PHASE III CLINICAL TRIALS
    Milling, Truman J.
    Refaai, Majed A.
    Sarode, Ravi
    Lewis, Brandon
    Mangione, Antoinette
    Durn, Billie L.
    Goldstein, Joshua N.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E26 - E26
  • [48] Four-factor prothrombin complex concentrate is associated with improved survival in trauma-related hemorrhage: A nationwide propensity-matched analysis
    Zeeshan, Muhammad
    Hamidi, Mohammad
    Feinstein, Ara J.
    Gries, Lynn
    Jehan, Faisal
    Sakran, Joseph
    Northcutt, Ashley
    O'Keeffe, Terence
    Kulvatunyou, Narong
    Joseph, Bellal
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2019, 87 (02): : 274 - 281
  • [49] Quality evaluation of case series describing four-factor prothrombin complex concentrate in oral factor Xa inhibitor-associated bleeding: a systematic review
    Costa, Olivia S.
    Baker, William L.
    Roman-Morillo, Yuani
    McNeil-Posey, Kelly
    Lovelace, Belinda
    White, C. Michael
    Coleman, Craig, I
    BMJ OPEN, 2020, 10 (11):
  • [50] Hemostatic effectiveness of four-factor prothrombin complex concentrate for treatment of factor Xa inhibitor-associated acute major bleeds: A meta-analysis
    Baker, Nicole L.
    Ida, Fidelia
    Wang, Rongrong
    Goldstein, Brahm
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 350 - 350
12345